ESTRO 2024 - Abstract Book

S5710

RTT - Patient experience and quality of life

ESTRO 2024

Conclusion:

Online MR-guided SABR for infra-diaphragmatic soft tissue metastases results mainly in mild to moderate symptoms in the patients’ self-reports, with fatigue, diarrhoea, and nausea increasing the most. The relation between fatigue and patients receiving systemic treatment before or in the SOFT trial follow-up period are still to be investigated. Conducting more detailed analyses of the reported symptom trajectory is essential. Ongoing analyses are presently concentrating on diverse OMD subgroups, treatment sites and concomitant systemic therapy.

Keywords: Oligometastatic, MR-Linac, PROs

References:

[1] Olson R et al. 2019. Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus

Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial. Int J Radiation Oncol Biol Phys, Vol. 105, No. 5, pp. 943e947, 2019. https://doi.org/10.1016/j.ijrobp.2019.08.041 [2] Langlais et al. 2022. Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data. Journal of Pain and Symptom Management. Vol. 63 No. 2 February 2022. https://doi.org/10.1016/j.jpainsymman.2021.07.031

2626

Digital Poster

Incidence of anxiety and depression in the first radiotherapy visit at an oncology center in Mexico

Mizada M Mohamed Garza 1 , Jose F Muñoz Lozano 1 , Andres M Morales Garcia 1 , Rafael Piñeiro Retif 1 , Oscar Vidal Gutierréz 2 1 Centro Universitario Contra El Cáncer, University Hospital “Dr. José Eleuterio González”, Radiation Oncology, Monterrey, Mexico. 2 Centro Universitario Contra El Cáncer, University Hospital “Dr. José Eleuterio González”, Oncology, Monterrey, Mexico